Form 8-K - Current report:
SEC Accession No. 0001213900-25-007029
Filing Date
2025-01-27
Accepted
2025-01-27 16:37:31
Documents
15
Period of Report
2025-01-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0228858-8k_pmgc.htm   iXBRL 8-K 45453
2 FORM OF NEW WARRANT ea022885801ex4-1_pmgc.htm EX-4.1 150147
3 FORM OF WARRANT INDUCEMENT AGREEMENT ea022885801ex10-1_pmgc.htm EX-10.1 55871
  Complete submission text file 0001213900-25-007029.txt   487090

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE elab-20250127.xsd EX-101.SCH 3027
5 XBRL LABEL FILE elab-20250127_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE elab-20250127_pre.xml EX-101.PRE 22797
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0228858-8k_pmgc_htm.xml XML 3963
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 25559598
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)